hepatic glucose output phenotype
Evidence from:
primary |
all sources
Related entities (5)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Fgf21 | regulates | hepatic glucose output | — | 1 |
| Glucose turnover | associated_with | hepatic glucose output | — | 1 |
| hyperinsulinemia | regulates | hepatic glucose output | — | 1 |
| tesaglitazar | regulates | hepatic glucose output | — | 1 |
| tesaglitazar | associated_with | hepatic glucose output | — | 1 |
Mentioned in (3)
Papers in which this entity is mentioned.
- An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. (2013)
- The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat. (2013)
- FGF21 promotes metabolic homeostasis via white adipose and leptin in mice. (2012)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| hepatic glucose output | phenotype | 3 | 4 |
| basal hgo | phenotype | 1 | 1 |
| hgo | phenotype | 1 | 2 |